1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.

DEA Summary Evaluation of MDPV (methylenedioxypyrovalerone)

DEA Summary Evaluation of MDPV (methylenedioxypyrovalerone)

  1. Snouter Fancier
    1-page commentary about MDPV chemistry, clinical effects, and legal status by DEA, from December 2010.

    Especially interesting is this statement:

    "Currently, MDPV is not a scheduled drug under the Controlled Substances Act (CSA). However, if intended for human consumption, MDPV can be considered an analogue of a schedule I drug under the CSA (Title 21 United States Code 813). Therefore, law enforcement cases involving MDPV can be prosecuted under the Federal Analogue Act of the CSA."

    mdpv, methylenedioxypyrovalerone, legality, dea, research-chemicals